Renowned for its excellence in trial work, Kirkland & Ellis LLP has vast experience handling bet-the-company litigation for generic pharmaceutical and manufacturing companies involving complex technical and scientific issues. The practice serves as primary counsel on a wide range of product liability and mass tort matters, including multi-district litigations, class actions, defect/recall investigations, and appeals. Mike Brock is a seasoned litigator based in Washington DC specializing in representing pharma and life sciences companies in product liability and mass torts. In Chicago, trial lawyer Donna Welch spearheads the firm’s representation of Gilead in multiple matters regarding its Covid-19 antiviral drug Veklury – including product liability action related to alleged manufacturing negligence and class action regarding its marketing and promotion. The team saw significant expansion in January 2025 with the addition of Allison Brown, Jessica Davidson, Geoffrey Wyatt, Nina Rose, and Christopher Cox from Skadden, Arps, Slate, Meagher & Flom LLP. Kim Bueno joined the team in May 2025 from King & Spalding LLP.
Legal 500 redaktioneller Kommentar
- Profil
- Soziale Medien
Kernmandanten
- AbbVie
- Allergan
- Crown Laboratories
- Eagle Pharmaceuticals
- Eli Lilly and Company
- Gilead Sciences
- GlaxoSmithKline
- Haleon
- Kenvue
- Ranbaxy Pharmaceuticals
Anwält*innen
Hall of fame
Die Anwält*innen an der Spitze ihres Berufsstands, die aufgrund ihres langjährigen Engagements in marktführender Arbeit von Wettbewerbern und Mandanten gleichermaßen geschätzt und anerkannt werden.
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Allison Brown
Kim Bueno
Weitere Kernanwält*innen
Mike Brock; Donna Welch; Allison Brown; Jessica Davidson; Geoffrey Wyatt; Nina Rose; Christopher Cox